Table 4.
Hematopoietic reconstitution
| Parameters | Overall cohort | Outpatient treatment | Hospital admission | P-value |
|---|---|---|---|---|
| Days to L <1.0 × 109/L | 4 (2–5) | 4 (3–5) | 4 (2–5) | 0.83 |
| Days to L ≥1.0 × 109/L | 14 (11–20) | 15 (13–20) | 13 (11–16) | 0.11 |
| Days in aplasia | 10 (7–15) | 11 (8–15) | 9 (7–11) | 0.11 |
| Days to N ≥0.5 × 109/L | 14 (12–20) | 14 (13–20) | 14 (12–16) | 0.23 |
| Platelets ≥20 × 109/L | ||||
| Platelet transfusion, n (%) | 15 (71) | 9 (64) | 6 (86) | 0.61 |
| Analysed ABSCTs, n (%) | 6 (29) | 5 (36) | 1 (14) | / |
| Days to platelets ≥20 × 109/L | 10 (9–16) | 10 (9–11) | 16 | / |
| Platelets ≥50 × 109/L | ||||
| Days to platelets ≥50 × 109/L | 14 (11–25) | 14 (11–22) | 14 (11–25) | 0.97 |
ABSCT autologous blood stem cell transplantation, L leucocytes, NA not available, N neutrophils. Unless otherwise indicated, data are given as medians (range)